5 insider filings
Quang X Pham, insider filing for CVKD
Show all 5
- 4Insider filing for CVKD
- 4Insider filing for CVKD
- 4Insider filing for CVKD
- 4Insider filing for CVKD
- 4Insider filing for CVKD
Quang X Pham, reporting
CVKD
Cadrenal Therapeutics, Inc. SEC filings
Every EDGAR filing for Cadrenal Therapeutics, Inc. (CVKD), newest first, with AI summaries and stories.
- Ticker
- CVKD
- CIK
- 1937993
- Sector
- Biotech and pharma
- Latest filing
- 5d
Next: 10-Q expected ~Nov 9 (deadline Nov 16) · earnings expected ~Nov 10
Filings
4Cadrenal Therapeutics, Inc.CVKDLIVE S-8Cadrenal Therapeutics, Inc.CVKDLIVE Cadrenal Therapeutics files S-8 form
- Filed S-8 on 2026-10-08
- Registers 323,542 shares under 2022 Plan
- Amendment approved by Board and shareholders on 2026-07-30
8-KCadrenal Therapeutics, Inc.CVKDLIVE Cadrenal Therapeutics initiates strategic review
- Initiated strategic process to evaluate value-maximizing opportunities
- Engaged Tungsten Advisors as exclusive financial advisor
- Pipeline includes CAD-1005, tecarfarin, frunexian, and CAD-2000
8-KCadrenal Therapeutics, Inc.CVKDLIVE S-8Cadrenal Therapeutics, Inc.CVKDLIVE 8-KCadrenal Therapeutics, Inc.CVKDLIVE 10-QCadrenal Therapeutics, Inc.CVKDLIVE 8-KCadrenal Therapeutics, Inc.CVKDLIVE SCHEDULE 13GCadrenal Therapeutics, Inc.CVKDLIVE Ownership stake disclosure by PNC FINANCIAL SERVICES GROUP, INC.
PNC FINANCIAL SERVICES GROUP, INC., filed by
DEFA14ACadrenal Therapeutics, Inc.CVKDLIVE ARSCadrenal Therapeutics, Inc.CVKDLIVE DEF 14ACadrenal Therapeutics, Inc.CVKDLIVE PRE 14ACadrenal Therapeutics, Inc.CVKDLIVE 8-KCadrenal Therapeutics, Inc.CVKDLIVE EFFECTCadrenal Therapeutics, Inc.CVKDLIVE 424B3Cadrenal Therapeutics, Inc.CVKDLIVE 8-KCadrenal Therapeutics, Inc.CVKDLIVE DCadrenal Therapeutics, Inc.CVKDLIVE S-3Cadrenal Therapeutics, Inc.CVKDLIVE 8-KCadrenal Therapeutics, Inc.CVKDLIVE 4Cadrenal Therapeutics, Inc.CVKDLIVE Quang X Pham, insider filing for CVKD
Quang X Pham, reporting
8-KCadrenal Therapeutics, Inc.CVKDLIVE 8-KCadrenal Therapeutics, Inc.CVKDLIVE 4Cadrenal Therapeutics, Inc.CVKDLIVE Quang X Pham, insider filing for CVKD
Quang X Pham, reporting
4Cadrenal Therapeutics, Inc.CVKDLIVE Quang X Pham, insider filing for CVKD
Quang X Pham, reporting
4Cadrenal Therapeutics, Inc.CVKDLIVE Quang X Pham, insider filing for CVKD
Quang X Pham, reporting
8-KCadrenal Therapeutics, Inc.CVKDLIVE 4Cadrenal Therapeutics, Inc.CVKDLIVE Quang X Pham, insider filing for CVKD
Quang X Pham, reporting
144Cadrenal Therapeutics, Inc.CVKDLIVE Quang X Pham, planned sale of CVKD shares
Quang X Pham, reporting
4Cadrenal Therapeutics, Inc.CVKDLIVE Quang X Pham, insider filing for CVKD
Quang X Pham, reporting
4Cadrenal Therapeutics, Inc.CVKDLIVE Quang X Pham, insider filing for CVKD
Quang X Pham, reporting
8-KCadrenal Therapeutics, Inc.CVKDLIVE 4Cadrenal Therapeutics, Inc.CVKDLIVE Quang X Pham, insider filing for CVKD
Quang X Pham, reporting
4Cadrenal Therapeutics, Inc.CVKDLIVE Quang X Pham, insider filing for CVKD
Quang X Pham, reporting
4Cadrenal Therapeutics, Inc.CVKDLIVE Quang X Pham, insider filing for CVKD
Quang X Pham, reporting
144Cadrenal Therapeutics, Inc.CVKDLIVE Quang X Pham, planned sale of CVKD shares
Quang X Pham, reporting
8-KCadrenal Therapeutics, Inc.CVKDLIVE 10-QCadrenal Therapeutics, Inc.CVKDLIVE 8-KCadrenal Therapeutics, Inc.CVKDLIVE EFFECTCadrenal Therapeutics, Inc.CVKDLIVE 424B3Cadrenal Therapeutics, Inc.CVKDLIVE DCadrenal Therapeutics, Inc.CVKDLIVE 8-KCadrenal Therapeutics, Inc.CVKDLIVE 424B5Cadrenal Therapeutics, Inc.CVKDLIVE 10-KCadrenal Therapeutics, Inc.CVKDLIVE 8-KCadrenal Therapeutics, Inc.CVKDLIVE